US20060222647A1
(en)
*
|
1993-05-27 |
2006-10-05 |
Beavo Joseph A |
Methods and compositions for modulating the activity of PDE5
|
GB9301192D0
(en)
|
1993-06-09 |
1993-06-09 |
Trott Francis W |
Flower shaped mechanised table
|
CA2234060A1
(en)
*
|
1995-10-06 |
1997-04-10 |
Arch Development Corporation |
Methods and compositions for viral enhancement of cell killing
|
US20050065161A1
(en)
*
|
1996-02-02 |
2005-03-24 |
Nitromed, Inc. |
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
|
IL120266A
(en)
|
1996-02-28 |
2005-05-17 |
Pfizer |
Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
|
GB9608408D0
(en)
|
1996-04-23 |
1996-06-26 |
Adams Michael A |
Treatment of erectile dysfunction
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
GR1002847B
(en)
|
1997-05-06 |
1998-01-27 |
|
Use of micropostol and/or micropostol acid for the preparation of a medicine for the therapeutic treatiment of problems related to the erection
|
DE69833254T2
(en)
*
|
1997-06-23 |
2006-11-02 |
Cellegy Pharmaceuticals, Inc., Brisbane |
MICRODOSIS THERAPY OF VASCULAR EXPOSURE BY NO-DONORS
|
US6593369B2
(en)
|
1997-10-20 |
2003-07-15 |
Vivus, Inc. |
Methods, compositions, and kits for enhancing female sexual desire and responsiveness
|
US20040044080A1
(en)
*
|
1997-10-28 |
2004-03-04 |
Place Virgil A. |
Treatment of dyspareunia with topically administered nitroglycerin formulations
|
CA2306837C
(en)
*
|
1997-10-28 |
2007-05-08 |
Asivi, Llc. |
Treatment of female sexual dysfunction
|
US20040014761A1
(en)
*
|
1997-10-28 |
2004-01-22 |
Place Virgil A. |
Treatment of female sexual dysfunction with phosphodiesterase inhibitors
|
US20020013304A1
(en)
*
|
1997-10-28 |
2002-01-31 |
Wilson Leland F. |
As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
|
US6548490B1
(en)
*
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
US6403597B1
(en)
|
1997-10-28 |
2002-06-11 |
Vivus, Inc. |
Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
|
AU734734B2
(en)
*
|
1997-10-28 |
2001-06-21 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
US6472425B1
(en)
|
1997-10-31 |
2002-10-29 |
Nitromed, Inc. |
Methods for treating female sexual dysfunctions
|
US6541487B1
(en)
*
|
1998-05-01 |
2003-04-01 |
R.T. Alamo Ventures I, Llc |
PDE III inhibitors for treating sexual dysfunction
|
US6465445B1
(en)
*
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
KR20060098400A
(en)
*
|
1998-06-11 |
2006-09-18 |
앙도르쉐르슈 인코포레이티드 |
PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
|
GR1003199B
(en)
|
1998-08-14 |
1999-09-01 |
|
Use of micropostol and/or micropostol acid for the preparation of a medicine for the therapeutic threatment of problemes related to the female sexual malfunction
|
GB9818524D0
(en)
*
|
1998-08-25 |
1998-10-21 |
Futura Medical Limited |
Inorgasmia treatment
|
FR2786101B1
(en)
*
|
1998-11-24 |
2002-07-05 |
Aventis Laboratoire |
USE OF NICERGOLIN IN THE TREATMENT OF SPASTICITY
|
US20070191320A1
(en)
*
|
1998-12-10 |
2007-08-16 |
Nexmed Holdings, Inc. |
Methods of treatment for female sexual arousal disorder
|
US6825234B2
(en)
|
1998-12-10 |
2004-11-30 |
Nexmed (Holdings) , Inc. |
Compositions and methods for amelioration of human female sexual dysfunction
|
SE9900025D0
(en)
*
|
1999-01-08 |
1999-01-08 |
Synphora Ab |
Method and composition for treatment of female sexual dysfunction
|
WO2000051978A1
(en)
|
1999-03-01 |
2000-09-08 |
Nitromed, Inc. |
Nitrosated and nitrosylated prostaglandins, compositions and metods of use
|
PL350917A1
(en)
|
1999-03-05 |
2003-02-10 |
Procter & Gamble |
C16 unsaturated fp-selective prostaglandins analogs
|
US6613768B1
(en)
|
1999-04-30 |
2003-09-02 |
Lilly Icos Llc |
Treatment of female arousal disorder
|
IT1312310B1
(en)
|
1999-05-07 |
2002-04-15 |
Recordati Ind Chimica E Farma |
USE OF SELECTIVE 1B ADRENERGIC RECEPTOR ANTAGONISTS TO IMPROVE SEXUAL DYSFUNCTION
|
US20050100618A1
(en)
*
|
1999-07-01 |
2005-05-12 |
Thompson Ronald J. |
Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of Icariin, a herbal product produced from the Epimedium genus of the Berberidaceal family of plants, for the treatment of sexual dysfunction
|
US20050186294A1
(en)
*
|
1999-07-01 |
2005-08-25 |
Thompson James M. |
Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of vardenafil for the treatment of female sexual dysfunction
|
IL139456A0
(en)
*
|
1999-11-08 |
2001-11-25 |
Pfizer |
Compounds for the treatment of female sexual dysfunction
|
US20050070499A1
(en)
*
|
1999-11-08 |
2005-03-31 |
Pfizer Inc. |
Compounds for the treatment of female sexual dysfunction
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
US20020013327A1
(en)
*
|
2000-04-18 |
2002-01-31 |
Lee Andrew G. |
Compositions and methods for treating female sexual dysfunction
|
US6762202B2
(en)
|
2000-05-09 |
2004-07-13 |
Nitromed, Inc. |
Infrared thermography and methods of use
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US6821978B2
(en)
|
2000-09-19 |
2004-11-23 |
Schering Corporation |
Xanthine phosphodiesterase V inhibitors
|
JP2004522710A
(en)
*
|
2000-11-17 |
2004-07-29 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Treatment of sexual dysfunction
|
US20020107230A1
(en)
*
|
2000-12-22 |
2002-08-08 |
Waldon R. Forrest |
Methods and formulations for the treatment of female sexual dysfunction
|
US20020132832A1
(en)
*
|
2001-01-05 |
2002-09-19 |
Mills Thomas M. |
Treatment of erectile dysfunction
|
WO2002069906A2
(en)
|
2001-03-06 |
2002-09-12 |
Cellegy Pharmaceuticals, Inc. |
Compounds and methods for the treatment of urogenital disorders
|
US20030022875A1
(en)
*
|
2001-07-27 |
2003-01-30 |
Wilson Leland F. |
As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness
|
US6607525B2
(en)
|
2001-08-01 |
2003-08-19 |
Nicolas Franco |
Apparatus and method for treating urinary stress incontinence
|
WO2003042216A1
(en)
*
|
2001-11-09 |
2003-05-22 |
Schering Corporation |
Polycyclic guanine derivative phosphodiesterase v inhibitors
|
US20030108512A1
(en)
*
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
US6673841B2
(en)
*
|
2001-12-20 |
2004-01-06 |
Whan In Pharm. Co., Ltd. |
Alprostadil alkyl ester-containing composition for external application
|
US20030158184A1
(en)
*
|
2001-12-21 |
2003-08-21 |
Garvey David S. |
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
|
EP1340503A1
(en)
*
|
2002-03-01 |
2003-09-03 |
CHIESI FARMACEUTICI S.p.A. |
Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
|
US6899890B2
(en)
*
|
2002-03-20 |
2005-05-31 |
Kv Pharmaceutical Company |
Bioadhesive drug delivery system
|
GB0208704D0
(en)
*
|
2002-04-16 |
2002-05-29 |
Futura Medical Dev Ltd |
Condom
|
US7005408B2
(en)
*
|
2002-05-01 |
2006-02-28 |
Mcneil-Ppc, Inc. |
Warming and nonirritating lubricant compositions and method of comparing irritation
|
RU2306133C2
(en)
*
|
2002-05-01 |
2007-09-20 |
МакНЕЙЛ-ППС, ИНК. |
Warming and nonirritating lubricating fungicidal gel-like compositions
|
US20040059190A1
(en)
*
|
2002-07-08 |
2004-03-25 |
Matlock David L. |
Method of colpoplasty
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
MXPA05004278A
(en)
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Cosmetic and pharmaceutical foam.
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US7645803B2
(en)
|
2005-05-09 |
2010-01-12 |
Foamix Ltd. |
Saccharide foamable compositions
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US7306812B2
(en)
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
CN1787824A
(en)
*
|
2003-06-25 |
2006-06-14 |
有限会社循环器研究所 |
External preparation for improving coital function
|
ITMI20031428A1
(en)
*
|
2003-07-11 |
2005-01-12 |
Indena Spa |
COMBINATIONS OF VASOACTIVE AGENTS AND THEIR USE FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US20050181057A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Rosenberg Paul K. |
Vaginal lubricant
|
US20050187429A1
(en)
*
|
2004-02-23 |
2005-08-25 |
Poppas Dix P. |
Vaginal rejuvenation
|
US20050244402A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Villanueva Julie M |
Absorption of pain-causing agents
|
US6949067B1
(en)
|
2004-05-11 |
2005-09-27 |
Dann Jeffrey A |
Device and method for enhancing female sexual stimulation
|
PT1750766E
(en)
*
|
2004-05-11 |
2013-09-30 |
Emotional Brain Bv |
Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
|
US8147399B2
(en)
|
2004-05-11 |
2012-04-03 |
Gloth David A |
Device and method for applying a biocompatible substance to a female stimulation device
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
RS20070166A
(en)
*
|
2004-10-20 |
2008-09-29 |
Endorecherche Inc., |
Sex steroid precursors alone or in combination with a selective estrogen receptor modulator...
|
US8506934B2
(en)
|
2005-04-29 |
2013-08-13 |
Robert I. Henkin |
Methods for detection of biological substances
|
WO2007016361A2
(en)
|
2005-07-29 |
2007-02-08 |
Concert Pharmaceuticals Inc. |
Novel pharmaceutical compounds
|
JP2009507925A
(en)
*
|
2005-09-13 |
2009-02-26 |
エラン ファーマ インターナショナル リミテッド |
Nanoparticle tadalafil formulation
|
US8148560B2
(en)
*
|
2005-09-23 |
2012-04-03 |
Teva Women's Health, Inc. |
Vaginal tablets comprising misoprostol and methods of making and using the same
|
TR201815853T4
(en)
|
2005-10-12 |
2018-11-21 |
Besins Healthcare Sarl |
Testosterone gel for use in the treatment of hypogonadism.
|
US20090215731A1
(en)
|
2005-10-19 |
2009-08-27 |
Chavah Pty Ltd. |
Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
|
JP2009514969A
(en)
|
2005-11-09 |
2009-04-09 |
コンビナトアールエックス インコーポレーティッド |
Methods, compositions, and kits for treating medical conditions
|
EP1790343A1
(en)
*
|
2005-11-11 |
2007-05-30 |
Emotional Brain B.V. |
Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
|
US8703179B2
(en)
*
|
2006-05-11 |
2014-04-22 |
Kimberly-Clark Worldwide, Inc. |
Mucosal formulation
|
JP5193196B2
(en)
|
2006-06-02 |
2013-05-08 |
ペア ツリー ウーマンズ ヘルス ケア |
Methods of treatment for atrophic vaginitis
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
EP1925307A1
(en)
|
2006-11-03 |
2008-05-28 |
Emotional Brain B.V. |
Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
WO2008095136A2
(en)
|
2007-01-31 |
2008-08-07 |
Henkin Robert I |
Methods for detection of biological substances
|
MX2009009937A
(en)
*
|
2007-03-23 |
2009-09-24 |
Univ California |
Treatment of female sexual dysfunction by compounds that positively modulate ampa-type glutamate receptors.
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
US8268806B2
(en)
|
2007-08-10 |
2012-09-18 |
Endorecherche, Inc. |
Pharmaceutical compositions
|
US20090197892A1
(en)
*
|
2007-08-21 |
2009-08-06 |
Nawaz Ahmad |
Anhydrous compositions useful for attaining enhanced sexual wellness
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
EP2242476A2
(en)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
US20090185995A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Stacy Vochecowicz |
Lubricious, non-tacky personal lubricant
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
US8580801B2
(en)
|
2008-07-23 |
2013-11-12 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
US8650937B2
(en)
|
2008-09-19 |
2014-02-18 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
US8308678B2
(en)
|
2008-09-23 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Pre-filled applicator device
|
EP2349076B1
(en)
*
|
2008-10-10 |
2018-06-13 |
Kirk Promotion LTD. |
A system, an apparatus for treating a sexual dysfunctional female patient
|
EP2381957B1
(en)
*
|
2009-01-13 |
2015-01-07 |
Lubris LLC |
Therapeutic modulation of vaginal epithelium boundary lubrication
|
US20100227925A1
(en)
*
|
2009-03-09 |
2010-09-09 |
Ruth Chatfield |
Sensitizing compound and method for increasing sexual sensitivity
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
US9408683B2
(en)
|
2009-05-27 |
2016-08-09 |
Parapatch, Inc. |
Method and device for treating female pelvic nerve dysfunction
|
CA2762066A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Cora St. Anne |
Method and device for female urinary incontinence
|
JP5947717B2
(en)
|
2009-06-19 |
2016-07-06 |
ナノフォーム ハンガリー リミテッド |
Nanostructured sildenafil base, pharmaceutically acceptable salts and co-crystals thereof, compositions thereof, methods of preparation thereof, and pharmaceutical compositions containing them
|
US20110002966A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Alex Lovett |
Vaginal Suppository System and Method
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
EP2724739B1
(en)
|
2009-07-30 |
2015-07-01 |
Tandem Diabetes Care, Inc. |
Portable infusion pump system
|
EP2482914A1
(en)
*
|
2009-09-29 |
2012-08-08 |
Koninklijke Philips Electronics N.V. |
Intrauterine electronic capsule for administering a substance
|
MX359879B
(en)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Topical tetracycline compositions.
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
CN102816099A
(en)
*
|
2011-06-09 |
2012-12-12 |
上海天伟生物制药有限公司 |
High-purity carboprost tromethamine, and preparation method and application thereof
|
ES2395801B1
(en)
*
|
2011-06-23 |
2014-06-06 |
María Carmen PARDINA PALLEJÀ |
"PENTOXIFILINA BY TRANSVAGINAL ROUTE FOR THE TREATMENT OF INFERTILITY"
|
WO2013012430A1
(en)
*
|
2011-07-19 |
2013-01-24 |
Riepl Michael S |
Dhea bioadhesive controlled release gel
|
US9320744B2
(en)
*
|
2011-10-19 |
2016-04-26 |
Dhea Llc |
DHEA bioadhesive controlled release gel
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HUE055562T2
(en)
|
2011-11-23 |
2021-11-29 |
Therapeuticsmd Inc |
Natural combination hormone replacement formulations and therapies
|
BR112014014308A2
(en)
|
2011-12-29 |
2017-06-13 |
Laboratorios Andrómaco S A |
vaginal ring that includes dhea or dhea sulfate and, optionally, an agent for modulating the release of the active ingredient, which can be used to increase ovarian reserve in women and to relieve symptoms associated with menopause.
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20150297601A1
(en)
|
2012-10-05 |
2015-10-22 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
EP3108245B1
(en)
|
2014-02-18 |
2020-07-22 |
Robert I. Henkin |
Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
|
EP3145489A1
(en)
|
2014-05-22 |
2017-03-29 |
TherapeuticsMD, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2016061615A1
(en)
|
2014-10-22 |
2016-04-28 |
Chavah Pty Ltd |
Methods of reducing mammographic breast density and/or breast cancer risk
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
AU2016343297A1
(en)
|
2015-10-22 |
2018-05-10 |
Havah Therapeutics Pty Ltd |
Methods of reducing mammographic breast density and/or breast cancer risk
|
WO2017147274A1
(en)
*
|
2016-02-24 |
2017-08-31 |
Eastern Virginia Medical School |
An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension
|
USD798462S1
(en)
|
2016-04-01 |
2017-09-26 |
Parapatch, Inc. |
Clitoral adhesive device
|
BR112018070199A2
(en)
|
2016-04-01 |
2019-01-29 |
Therapeuticsmd Inc |
pharmaceutical composition of steroid hormone
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
WO2017168174A1
(en)
|
2016-04-02 |
2017-10-05 |
N4 Pharma Uk Limited |
New pharmaceutical forms of sildenafil
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
AU2020257625A1
(en)
|
2019-04-17 |
2021-11-04 |
Compass Pathfinder Limited |
Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
WO2020243777A1
(en)
|
2019-06-03 |
2020-12-10 |
Havah Therapeutics Pty Ltd |
Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor and methods for use
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
US11717495B2
(en)
*
|
2020-03-16 |
2023-08-08 |
Vella Bioscience, Inc. |
Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
|